Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct 14;4(1):8-10.
doi: 10.1016/j.jimed.2020.10.010. eCollection 2021 Feb.

Bridging the preoperative gap of precision hepatectomy: Superstable homogeneous iodinated formulation technology

Zhe Wang  1 , Junqing Wang  2 , Gang Liu  3
Affiliations
Editorial

Bridging the preoperative gap of precision hepatectomy: Superstable homogeneous iodinated formulation technology

Zhe Wang et al. J Interv Med. .

Abstract

The in-situ post-embolization fluorescence-guided hepatectomy for hepatocellular carcinoma (HCC) requires precise embolic formulation that meets both preoperative and intraoperative needs of hepatobiliary surgeons. In this Editorial, we highlight the development of Superstable Homogeneous Iodinated Formulation Technology (SHIFT) for locoregional HCC treatment. It is believed that such an intelligent solution could resolve unmet formulation needs and make a major stride to bridge the preoperative gap of precision hepatectomy.

Keywords: Embolization; Fluorescence; HCC; Hepatectomy; ICG; SHIFT.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
A schematic diagram showing the differences between conventional procedures and the SHIFT method for the fluorescence-guided hepatectomy following the TAE/TACE treatment. a) The direct use of ICG on post-TAE/TACE treatment as a sequential manner. b) The use of conventional lipiodol-ICG mixture for TAE/TACE treatment followed by fluorescence-guided hepatectomy. c) The SHIFT method is introduced to counter the existing issues of conventional ICG-lipiodol formulation and bridge the preoperative gap of fluorescence-guided hepatectomy of HCC.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Ferlay J., Colombet M., Soerjomataram I. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Canc. 2019;144:1941–1953. - PubMed
    1. Ji M., Liu Z., Chang E.T. Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China. Sci Rep. 2018;8:12787. - PMC - PubMed
    1. Mohanty S., Rajaram R., Bilimoria K.Y. Assessment of non-surgical versus surgical therapy for localized hepatocellular carcinoma. J Surg Oncol. 2016;113:175–180. - PubMed
    1. Wang Y.X., De Baere T., Idee J.M. Transcatheter embolization therapy in liver cancer: an update of clinical evidences. Chin J Canc Res. 2015;27:96–121. - PMC - PubMed
    1. Galle P.R., Tovoli F., Foerster F. The treatment of intermediate stage tumours beyond TACE: from surgery to systemic therapy. J Hepatol. 2017;67:173–183. - PubMed

Publication types

LinkOut - more resources